Injective's Price at Risk of Violent Snap-Back or Brute Force Decline

Injective's price has been declining, currently trading at $4.11 and hugging its lower Bollinger Band.

The asset is in a textbook distribution territory, with prices below every meaningful moving average.

This situation is compounded by the broader DeFi sector struggling to find a coherent catalyst, as well as regulatory clarity in the U.S. failing to translate into sustained inflows for mid-cap L1 ecosystems like Injective's.

The technical setup is mixed, with bearish signals from the MACD and moving averages, but oversold readings from the Stochastic oscillator and RSI that historically associate with exhaustion bottoms.